TACROLIMUS IS SUPERIOR TO CYCLOSPORINE AFTER LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – A MULTICONTINENTAL REGISTRY-BASED PROPENSITY-SCORE MATCHED INTENTION-TO-TREAT ANALYSIS

Fredrik Åberg  ¹     Ville Sallinen  ²     Samuli Tuominen  ³     Réne Adam  ⁴     Vincent Hassan KARAM  ⁵     Darius Mirza  ⁶     Michael Heneghan  ⁷     Pål-Dag Line  ⁸     William Bennet  ⁹     Bo-Göran Ericzon  ¹⁰     Michal Grat  ¹¹     Peter Lodge  ¹²     Allan Rasmussen  ¹³     Moritz Schmelzle  ¹⁴     Douglas Thorburn  ¹⁵     Constantino Fondevila  ¹⁶     Ilkka Helanterä  ¹⁷     Arno Nordin  ^1    
1 Helsinki University Hospital, Helsinki, Finland
² Helsinki University Hospital / University of Helsinki, Helsinki, Finland
³ Medaffcon, Helsinki, Finland
⁴ AP-HP Hôpital Paul Brousse, Villejuif, France
⁵ Hôpital Paul Brousse, Villejuif, France
⁶ The Queen Elizabeth Hospital, Queen Elizabeth Medical Center, Birmingham, United Kingdom
⁷ King’s College Hospital, Institute of Liver Studies, London, United Kingdom
⁸ Rikshospitalet, Oóslo, Norway
⁹ Sahlgrenska University Hospital, Gothenburg, Sweden
¹⁰ Karolinska Institutet, Stockholm, Sweden
¹¹ Medical University of Warsaw, Warsaw, Poland
¹² St James & Seacroft University Hospital, Leeds, United Kingdom
¹³ University Hospital Copenhagen, Copenhagen, Denmark
¹⁴ Hannover Medical School, Hannover, Germany
¹⁵ Royal Free Hospital, London, United Kingdom
¹⁶ Hospital Universitario La Paz, Madrid, Spain
¹⁷ Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Topic
Hepatobiliary

Session
Autoimmune hepatitis and colangiopathies: Update on management and outcome

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)